Meta-analysis of the efficacy and safety of sevelamer as hyperphosphatemia therapy for hemodialysis patients

This study was designed to examine the relative safety and efficacy of sevelamer in the treatment of chronic kidney disease (CKD) patients in comparison to placebo, calcium carbonate (CC), or lanthanum carbonate (LC). The PubMed, Embase, Cochrane Library, and China National Knowledge Infrastructure...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Qian, Zhong, Yuanlong, Yu, Xiqiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243412/
https://www.ncbi.nlm.nih.gov/pubmed/37272189
http://dx.doi.org/10.1080/0886022X.2023.2210230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243412/
https://www.ncbi.nlm.nih.gov/pubmed/37272189
http://dx.doi.org/10.1080/0886022X.2023.2210230

Ejemplares similares